No Photo Available

Last Update

2016-04-15T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Alexander Lussow?

Dr. Alexander R. Lussow PhD

Senior Vice President, Business Development and Commercial Operations

QLT Inc.

Direct Phone: (604) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

QLT Inc.

250 - 887 Great Northern Way

Vancouver, British Columbia V5T 4T5

Canada

Company Description

QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the ... more

Find other employees at this company (153)

Background Information

Employment History

Chief Business Officer and Vice President of Business Development

Gryphon Sciences Inc

Head of Business Development

SangStat Medical Corporation

Managing Director

Broad Reach: The fastest way to sale

Education

Bachelor of Science degree

McGill University

PhD

immunology

University of Geneva , Switzerland

Web References (68 Total References)


Leadership | QLT Inc.

www.qltinc.com [cached]

Alexander Lussow Leadership | QLT Inc.

...
Alexander Lussow, Senior Vice President, Business Development and Commercial Operations
Alexander Lussow joined QLT in July 2006 as Vice President, Business Development and became Senior Vice President, Business Development and Commercial Operations in May 2008.
Dr. Lussow is responsible for QLT's business development activities, including product licensing, acquisitions and strategic partnering opportunities, as well as QLT's product manufacturing and supply chain.
Before joining QLT, Dr. Lussow was Gryphon Therapeutics' Chief Business Officer and Vice President of Business Development where he was responsible for the licensing of the company's products, the formation of strategic alliances, corporate communications and fund raising. Before joining Gryphon, Dr. Lussow served as the head of business development at Sangstat Medical Corporation (now wholly- owned by Genzyme Corp.). He also has broad experience in biotechnology management consulting, advising on venture financing, strategic business planning and licensing transactions for several biotechnology companies.
Dr. Lussow received his Bachelor of Science degree at McGill University in Montreal and his PhD in immunology at the University of Geneva, Switzerland. He has been an adjunct professor of pharmacology at the University of North Carolina, USA and has worked extensively for the World Health Organization (WHO) in West Africa.


Leadership | QLT Inc.

qlt.gssiwebs.com [cached]

Alexander Lussow

...
Alexander Lussow, SENIOR Vice President, Business Development and commercial operations


Leadership | QLT Inc.

qlt.gssiwebs.com [cached]

Alexander Lussow

...
Robert Butchofsky | Suzanne Cadden | Linda Lupini | Alexander Lussow | Christopher Muller | Cameron Nelson


Leadership | QLT Inc.

qlt.gssiwebs.com [cached]

Alexander Lussow | Alexander Lussow | Alexander Lussow, SENIOR Vice President, Business Development and commercial operations

...
Alexander Lussow | Alexander Lussow | Alexander Lussow, SENIOR Vice President, Business Development and commercial operations
...
Alexander Lussow | Alexander Lussow | Alexander Lussow, SENIOR Vice President, Business Development and commercial operations
...
Alexander Lussow
...
Robert Butchofsky | Suzanne Cadden | Linda Lupini | Alexander Lussow | Christopher Muller | Cameron Nelson
...
Alexander Lussow, Senior Vice President, Business Development and Commercial Operations
Alexander Lussow joined QLT in July 2006 as Vice President, Business Development and became Senior Vice President, Business Development and Commercial Operations in May 2008.
Dr. Lussow is responsible for QLT's business development activities, including product licensing, acquisitions and strategic partnering opportunities, as well as QLT's product manufacturing and supply chain.
Before joining QLT, Dr. Lussow was Gryphon Therapeutics' Chief Business Officer and Vice President of Business Development where he was responsible for the licensing of the company's products, the formation of strategic alliances, corporate communications and fund raising. Before joining Gryphon, Dr. Lussow served as the head of business development at Sangstat Medical Corporation (now wholly- owned by Genzyme Corp.). He also has broad experience in biotechnology management consulting, advising on venture financing, strategic business planning and licensing transactions for several biotechnology companies.
Dr. Lussow received his Bachelor of Science degree at McGill University in Montreal and his PhD in immunology at the University of Geneva, Switzerland. He has been an adjunct professor of pharmacology at the University of North Carolina, USA and has worked extensively for the World Health Organization (WHO) in West Africa.


Leadership | QLT Inc.

qlt.gssiwebs.com [cached]

Alexander Lussow

...
Robert Butchofsky | Suzanne Cadden | Linda Lupini | Alexander Lussow | Christopher Muller | Cameron Nelson

Similar Profiles

Other People with this Name

Other people with the name Lussow

Kelli Lussow
District 214

Bill Lussow
Bespoke Commercial Real Estate LLC

Tina Lussow

Bret Lussow
Harrington Hoists Inc

Tyler Lussow
Ithaca College

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory